JP6660401B2 - 網膜色素上皮の細胞を保護するためのノルビキシン含有組成物 - Google Patents

網膜色素上皮の細胞を保護するためのノルビキシン含有組成物 Download PDF

Info

Publication number
JP6660401B2
JP6660401B2 JP2017556593A JP2017556593A JP6660401B2 JP 6660401 B2 JP6660401 B2 JP 6660401B2 JP 2017556593 A JP2017556593 A JP 2017556593A JP 2017556593 A JP2017556593 A JP 2017556593A JP 6660401 B2 JP6660401 B2 JP 6660401B2
Authority
JP
Japan
Prior art keywords
norbixin
composition
bixin
mammal
body weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017556593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018518460A5 (enExample
JP2018518460A (ja
Inventor
ラフォン，ルネ
ヴェイエ，スタニスラ
サヘル，ジョゼ−アラン
フォンテーヌ，ヴァレリー
エレナ，ピエール−ポール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sorbonne Universite
Original Assignee
Sorbonne Universite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorbonne Universite filed Critical Sorbonne Universite
Publication of JP2018518460A publication Critical patent/JP2018518460A/ja
Publication of JP2018518460A5 publication Critical patent/JP2018518460A5/ja
Application granted granted Critical
Publication of JP6660401B2 publication Critical patent/JP6660401B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
JP2017556593A 2015-04-30 2016-04-28 網膜色素上皮の細胞を保護するためのノルビキシン含有組成物 Active JP6660401B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1553957 2015-04-30
FR1553957A FR3035589B1 (fr) 2015-04-30 2015-04-30 Composition pour la protection des cellules de l'epithelium pigmentaire retinien
PCT/FR2016/051001 WO2016174360A1 (fr) 2015-04-30 2016-04-28 Composition contenant de la norbixine pour la protection des cellules de l'epithelium pigmentaire retinien

Publications (3)

Publication Number Publication Date
JP2018518460A JP2018518460A (ja) 2018-07-12
JP2018518460A5 JP2018518460A5 (enExample) 2019-04-25
JP6660401B2 true JP6660401B2 (ja) 2020-03-11

Family

ID=53758384

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017556593A Active JP6660401B2 (ja) 2015-04-30 2016-04-28 網膜色素上皮の細胞を保護するためのノルビキシン含有組成物

Country Status (15)

Country Link
US (1) US10314804B2 (enExample)
EP (1) EP3288551B1 (enExample)
JP (1) JP6660401B2 (enExample)
KR (1) KR102575312B1 (enExample)
CN (1) CN107708685B (enExample)
AU (1) AU2016256637A1 (enExample)
BR (1) BR112017023264A2 (enExample)
CA (1) CA2984405C (enExample)
ES (1) ES2752061T3 (enExample)
FR (1) FR3035589B1 (enExample)
IL (1) IL255276A0 (enExample)
MX (1) MX376021B (enExample)
PL (1) PL3288551T3 (enExample)
RU (1) RU2715889C2 (enExample)
WO (1) WO2016174360A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
CA3098868A1 (en) 2018-05-03 2019-11-07 L.E.A.F. Holdings Group Llc Carotenoid compositions and uses thereof
KR20200134935A (ko) 2019-05-24 2020-12-02 (주)비지엔케어 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 약학 조성물
EP4054637A4 (en) * 2019-11-06 2023-12-20 L.E.A.F Holdings Group LLC CAROTINOID COMPOSITIONS AND USES THEREOF
FR3105790B1 (fr) * 2019-12-26 2022-01-14 Biophytis Composés chimiques ciblant l’œil et leur utilisation dans le traitement de maladies oculaires
KR20210008884A (ko) 2021-01-08 2021-01-25 (주)비지엔케어 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 조성물 및 기능성 식품 조성물
TWI894483B (zh) * 2022-08-24 2025-08-21 鼎赫生物科技股份有限公司 一種組合物用於治療眼睛疾病之醫藥品用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1154172A (fr) 1955-07-05 1958-04-03 Rollei Werke Franke Heidecke étui de protection pour appareils photographiques
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders
CA2528718A1 (en) * 2003-06-20 2004-12-29 Alcon, Inc. Treatment of amd with combination of ingredients
US7887847B2 (en) * 2004-05-08 2011-02-15 Paul Jr Edward L Nutritional supplement for treatment of ocular diseases
EP1814540A2 (en) * 2004-11-16 2007-08-08 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
JP2008179632A (ja) * 2006-12-29 2008-08-07 Fuji Chem Ind Co Ltd 抗酸化剤
JP5550854B2 (ja) * 2009-06-10 2014-07-16 理研ビタミン株式会社 一重項酸素消去剤
FR2947173B1 (fr) 2009-06-25 2012-01-27 Inst Biophytis Composition alimentaire destinee a la protection solaire
JP2012097003A (ja) * 2010-10-29 2012-05-24 Gifu City ビキシン誘導体及び細胞保護剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)

Also Published As

Publication number Publication date
CA2984405C (fr) 2024-01-23
IL255276A0 (en) 2017-12-31
ES2752061T3 (es) 2020-04-02
PL3288551T3 (pl) 2020-04-30
CA2984405A1 (fr) 2016-11-03
FR3035589A1 (fr) 2016-11-04
JP2018518460A (ja) 2018-07-12
KR102575312B1 (ko) 2023-09-06
BR112017023264A2 (pt) 2018-08-07
RU2017141462A (ru) 2019-05-31
US20180289651A1 (en) 2018-10-11
MX2017013918A (es) 2018-04-24
AU2016256637A1 (en) 2017-12-14
EP3288551A1 (fr) 2018-03-07
US10314804B2 (en) 2019-06-11
CN107708685B (zh) 2021-09-21
RU2715889C2 (ru) 2020-03-04
EP3288551B1 (fr) 2019-07-31
WO2016174360A9 (fr) 2017-11-16
RU2017141462A3 (enExample) 2019-09-12
CN107708685A (zh) 2018-02-16
FR3035589B1 (fr) 2019-12-13
WO2016174360A1 (fr) 2016-11-03
KR20180011777A (ko) 2018-02-02
MX376021B (es) 2025-03-07

Similar Documents

Publication Publication Date Title
JP6660401B2 (ja) 網膜色素上皮の細胞を保護するためのノルビキシン含有組成物
Robles-Rivera et al. Adjuvant therapies in diabetic retinopathy as an early approach to delay its progression: the importance of oxidative stress and inflammation
KR101660195B1 (ko) 크릴 오일과 반응한 아스타잔틴 조성물 및 관련 방법
Kalt et al. Recent research on polyphenolics in vision and eye health
Liu et al. Visible light-induced lipid peroxidation of unsaturated fatty acids in the retina and the inhibitory effects of blueberry polyphenols
US20170143646A1 (en) Effect of lipophilic nutrients on diabetic eye diseases
US9849096B2 (en) Neuroprotective effect of carotenoids in brain
JP6432913B2 (ja) 黄斑変性症の治療のためのビクサ・オレラナ由来組成物
US9351982B2 (en) Krill oil and reacted astaxanthin composition and associated method
WO2017135466A1 (ja) キサントフィルとヒシ属植物の加工物を含有する組成物
JP6148780B1 (ja) キサントフィルとヒシ属植物の加工物を含有する組成物
Das et al. Clinical management of eye diseases: carotenoids and their nanoformulations as choice of therapeutics
Ketsutham et al. Herb-derived Compounds and Other Potential Molecules for Non-exudative Age-related Macular Degeneration (AMD): A Systematic Review.
Delmas et al. Current Advances in the Combination of Fatty Acids and Resveratrol to Fight Ocular Diseases
Gao et al. The Comparative Protective Effects of Ganoderma Spores Lipid and Fish Oil on N‐Methyl‐N‐Nitrosourea‐Induced Photoreceptor Cell Lesion in Rats
Maiuolo et al. Potential properties of natural nutraceuticals and antioxidants in eye protection
Bulloj et al. Grapes and Vision
Pawaskar et al. Dietary supplements and drugs available in India along with the mechanism of action and clinical trial data for the medical management of age related macular degeneration (AMD)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190312

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190312

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20190312

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190320

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190409

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190709

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20190709

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190709

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191203

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200204

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200207

R150 Certificate of patent or registration of utility model

Ref document number: 6660401

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250